我們已在上線！進一步了解

BYAH

Park Ha Biological Technology Co

BYAH

市值 US$175萬

2.20 USD

-0.19

7.95%

收盤時已更新 10月16日下午4:00 EDT

1天

-7.95%

5天

-10.2%

1個月

-7.17%

3個月

-35.1%

6個月

-75.66%

今年迄今

-96.77%

1年

-98.58%

5年

-99.86%

10年

-99.86%

關於： Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

員工： 40

必需消費品家庭與個人用品

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 100%

負面 0%

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd.

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Park Ha Biological Technology Co., Ltd. Lawsuit - BYAH

BYAH allegedly structured its IPO with a public float of just 1,200,000 shares, representing less than 5% of the company, a structure the lawsuit contends enabled coordinated price manipulation before BYAH shares collapsed 93% in one session. BYAH allegedly structured its IPO with a public float of just 1,200,000 shares, representing less than 5% of the company, a structure the lawsuit contends enabled coordinated price manipulation before BYAH shares collapsed 93% in one session.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Park Ha Biological Technology Co., Ltd. Lawsuit - BYAH

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd.

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

PHH, BYAH Deadline: Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”). Park Ha develops and sells skincare and cosmetics products.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is.

PHH, BYAH Deadline: Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.

PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

SueWallSt Reminds Park Ha Biological Technology Co. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - BYAH

BYAH CFO Xiaoyan Zhu since 2016 signed the December 2024 registration statement that the lawsuit contends omitted the promotional scheme behind BYAH's 93% stock collapse. NEW YORK, Sept.

SueWallSt Reminds Park Ha Biological Technology Co. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - BYAH

PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact Levi & Korsinsky

A securities class action traces a seven-month sequence from Park Ha Biological Technology Co., Ltd.'s December 2024 public debut at $4.00 per share to its July 2025 surge above $41.49, followed by a 93% single-session collapse to $2.99 on July 8, 2025, which erased more than $1 billion in market value without any company announcement.

BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact Levi & Korsinsky

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – BYAH

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – BYAH

查看新聞排名

價格圖表採用Lightweight Charts™實作